Transcription Factor Sp1 Expression Is Upregulated in Human Glomerulonephritis: Correlation with pSmad2/3 and p300 Expression and Renal Injury

REFERENCES

• Sporn MB, Roberts AB. Transforming growth factor-beta: Recent progress and new challenges. J Cell Biol. 1992;119:1017–1021.
   PubMed Web of Science ®Google Scholar
• Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286–1292.
   PubMed Web of Science ®Google Scholar
• Border WA, Noble NA. TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int. 1997;51:1388–1396.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Noble NA, Cohen AH, Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 1996;49:461–469.
   PubMed Web of Science ®Google Scholar
• Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–791.
   PubMed Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370:341–347.
   PubMed Web of Science ®Google Scholar
• Nakao A, Imamura T, Souchelnytskyi S, TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J. 1997;16:5353–5362.
   PubMed Web of Science ®Google Scholar
• Miyazono K, ten Dijke P, Heldin CH. TGF-beta signaling by Smad proteins. Adv Immunol. 2000;75:115–157.
   PubMed Web of Science ®Google Scholar
• Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 1996;87:1215–1224.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng X, We R, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 1996;383:168–172.
   PubMed Web of Science ®Google Scholar
• Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J. 1998;17:3091–3100.
   PubMed Web of Science ®Google Scholar
• Zawel L, Dai JL, Buckhaults P, Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1998;1:611–617.
   PubMed Web of Science ®Google Scholar
• Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. Embo J. 2000;19:1745–1754.
   PubMed Web of Science ®Google Scholar
• Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.
   PubMed Web of Science ®Google Scholar
• de Caestecker MP, Yahata T, Wang D, The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem. 2000;275:2115–2122.
   PubMedGoogle Scholar
• Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP, Wang XF. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell. 1998;9:3309–3319.
   PubMed Web of Science ®Google Scholar
• Kassimatis TI, Giannopoulou I, Koumoundourou D, Theodorakopoulou E, Varakis I, Nakopoulou L. Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: Correlation with renal injury. J Cell Mol Med. 2006;10:908–921.
   PubMedGoogle Scholar
• Kanamaru Y, Nakao A, Tanaka Y, Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells. Nephron Exp Nephrol. 2003;95:e36–e42.
   Google Scholar
• Suske G. The Sp-family of transcription factors. Gene. 1999;238:291–300.
   PubMed Web of Science ®Google Scholar
• Datta PK, Blake MC, Moses HL. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between Smads and Sp1. J Biol Chem. 2000;275:40014–40019.
   PubMed Web of Science ®Google Scholar
• Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001;276:6983–6992.
   PubMedGoogle Scholar
• Inagaki Y, Nemoto T, Nakao A, Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem, 2001;276:16573–16579.
   PubMedGoogle Scholar
• Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription. J Biol Chem. 2000;275:39237–39245.
   PubMedGoogle Scholar
• Pardali K, Kurisaki A, Moren A, ten Dijke P., Kardassis D, Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000;275:29244–29256.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang X, Salmon M, Lin X, Zehner ZE. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta. 2007;1773:427–439.
   PubMed Web of Science ®Google Scholar
• Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Rheumatology (Oxford). 2006;45: 157–165.
   PubMedGoogle Scholar
• Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene. 2004;23:1656–1667.
   PubMed Web of Science ®Google Scholar
• Bussolati G, Gugliotta P, Volante M, Pace M, Papotti M. Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology. 1997;31:400–407.
   PubMed Web of Science ®Google Scholar
• Wang L, Wei D, Huang S, Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 2003;9:6371–6380.
   PubMed Web of Science ®Google Scholar
• Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP. Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem. 1997;272:2901–2913.
   PubMed Web of Science ®Google Scholar
• Wang L, Guan X, Gong W, Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis. 2005;22:205–213.
   PubMedGoogle Scholar
• Abdelrahim M, Liu S, Safe S. Induction of endoplasmic reticulum-induced stress genes in Panc-1 pancreatic cancer cells is dependent on Sp proteins. J Biol Chem. 2005;280: 16508–16513.
   PubMedGoogle Scholar
• Gu L, Ni Z, Qian J, Tomino Y. Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. Nephron Exp Nephrol. 2007;106:e1–e10.
   Google Scholar
• Chen G, Wang D, Vikramadithyan R, Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry. 2004;43:4971–4977.
   PubMed Web of Science ®Google Scholar
• Chen Y, Currie RW. Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflamm Res. 2005;54:338–343.
   PubMedGoogle Scholar
• Meissner M, Stein M, Urbich C, PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation. Circ Res. 2004;94:324–332.
   PubMedGoogle Scholar